Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure

This publication has 26 references indexed in Scilit:

• Renal insufficiency as an independent predictor of mortality among women with heart failure
  Journal of the American College of Cardiology, 2004
• Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure
  The American Journal of Cardiology, 2004
• Endothelin A Receptor Antagonism in Experimental Congestive Heart Failure Results in Augmentation of the Renin-Angiotensin System and Sustained Sodium Retention
  Circulation, 2004
• Angiotensin II in the Evolution of Experimental Heart Failure
  Hypertension, 1996
• Comparison of Chronic Neutral Endopeptidase Inhibition and Furosemide in an Ovine Model of Heart Failure
  Journal of Cardiovascular Pharmacology, 1996
• A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
  Journal of Clinical Investigation, 1995
• Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor
  Kidney International, 1990
• Further investigations on the Atrial Natriuretic Factor (ANF)-induced inhibition of the growth and steroidogenic capacity of rat adrenal zona glomerulosa in vivo
  The Journal of Steroid Biochemistry and Molecular Biology, 1988
• Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments
  Life Sciences, 1988
• Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human
  Science, 1986